[DNLI] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -10.16%
YoY- -16.22%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 145,149 0 0 0 0 0 0 -
PBT -22,887 -21,844 -22,134 -21,320 -19,354 -30,611 -18,344 15.84%
Tax -807 0 0 0 90 0 0 -
NP -22,887 -21,844 -22,134 -21,320 -19,354 -30,611 -18,344 15.84%
Tax Rate - - - - - - - -
Total Cost 168,036 21,844 22,134 21,320 19,354 30,611 18,344 336.03%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -15.77 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.74 -0.27 -0.32 -2.36 -2.15 -4.51 -3.37 -63.50%
EPS Diluted -0.74 -0.27 -0.32 -2.36 -2.15 -4.51 -3.37 -63.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.